Field | Row 1 |
---|---|
adsh | 0001321655-25-000066 |
cik | 1321655 |
name | PALANTIR TECHNOLOGIES INC. |
sic | 7372 |
countryba | US |
stprba | CO |
cityba | DENVER |
zipba | 80202 |
bas1 | 1200 17TH STREET |
bas2 | FLOOR 15 |
baph | 720-358-3679 |
countryma | US |
stprma | CO |
cityma | DENVER |
zipma | 80202 |
mas1 | 1200 17TH STREET |
mas2 | FLOOR 15 |
countryinc | |
stprinc | |
ein | 680551851 |
former | PALANTIR TECHNOLOGIES INC |
changed | 20050324 |
afs | 1-LAF |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250506 |
accepted | 2025-05-05 18:15:00.0 |
prevrpt | 0 |
detail | 1 |
instance | pltr-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001321655-25-000066 | 20250331 | Stock Repurchased During Period Shares | 211000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20241231 | Accrued Liabilities Current | 427046000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 125817000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
0001321655-25-000066 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Authorized | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Outstanding | 96003000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20240331 | Comprehensive Income Net Of Tax | 99009000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Cost Of Revenue | 116256000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Deferred Revenue Current | 259624000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Earnings Per Share Basic | 0.0900 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 223316000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Increase Decrease In Contract With Customer Liability | -6849000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Investment Income Interest | 43352000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Net Cash Provided By Used In Financing Activities | 75248000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -4622000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Profit Loss | 3686000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 628494000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= U S; | ||
0001321655-25-000066 | 20240331 | Selling And Marketing Expense | 193177000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Stockholders Equity | 5424155000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2200000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3475561000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5649613000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5544083000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5094407000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 91132000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -2994000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 13574000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -10000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 83840000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 155646000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Assets Current | 6282599000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Cash And Cash Equivalents At Carrying Value | 2098524000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1015005000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Authorized | 2700000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Outstanding | 2338795000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Value | 2339000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Value | 2360000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | 541000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Investment Income Interest | 50441000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Net Cash Provided By Used In Financing Activities | -28897000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Net Income Loss Attributable To Noncontrolling Interest | 541000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Income Loss | 176048000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Lease Liability Noncurrent | 200177000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Lease Right Of Use Asset | 209348000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Assets Noncurrent | 205301000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -1236000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 3853000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -6521000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20250331 | Other Liabilities Noncurrent | 12489000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Payments To Acquire Property Plant And Equipment | 2664000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 751746000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 350627000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Proceeds From Stock Options Exercised | 66584000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Property Plant And Equipment Net | 39669000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Retained Earnings Accumulated Deficit | -4973392000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 335373000.0000 | USD | 1 | us-gaap/2025 | Business Segments= Government Operating Segment; Consolidation Items= Operating Segments; | ||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 63201000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= G B; | ||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 23900000.0000 | USD | 1 | us-gaap/2025 | Type Of Arrangement= Investment Agreement; Type Of Contract= Commercial Contract; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 801000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 85404000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -4973392000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 9721000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 10000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 66570000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Stock Repurchased During Period Value | 17998000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 2348679000.0000 | shares | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Accounts Payable Current | 103000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Shares Issued | 2359663000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Shares Outstanding | 95401000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Outstanding | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20241231 | Customer Deposit Noncurrent | 1663000.0000 | USD | 0 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20241231 | Deferred Revenue Noncurrent | 39885000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | General And Administrative Expense | 163639000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Increase Decrease In Other Operating Liabilities | -13247000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Liabilities | 1246477000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Liabilities | 1217944000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Net Cash Provided By Used In Investing Activities | -1390277000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Net Income Loss | 214031000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Noncash Consideration | -11907000.0000 | USD | 1 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20240331 | Operating Income Loss | 80881000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Material Reconciling Items; | ||
0001321655-25-000066 | 20241231 | Operating Lease Right Of Use Asset | 200740000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -6521000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 2617000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20241231 | Other Liabilities Noncurrent | 13685000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Operating Activities Cash Flow Statement | 3531000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Profit Loss | 106071000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 406389000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= U S; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 883855000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 165707000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= Rest Of World; | ||
0001321655-25-000066 | 20250331 | Selling And Marketing Expense | 236309000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Share Based Compensation | 125651000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 10398181000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 7000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 83823000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 17000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Repurchased During Period Shares | 368000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stock Repurchased During Period Value | 17998000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 2400107000.0000 | shares | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Accounts Receivable Net Current | 575048000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Assets | 6340884000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Accrued Liabilities Current | 371061000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Additional Paid In Capital | 10193970000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
0001321655-25-000066 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Authorized | 20000000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Issued | 2338795000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Shares Issued | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20231231 | Common Stock Shares Outstanding | 2200128000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Common Stock Shares Outstanding | 2226963000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 220334000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Customer Deposit Current | 231077000.0000 | USD | 0 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20250331 | Debt And Equity Securities Unrealized Gain Loss | -10688000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Liabilities And Stockholders Equity | 6736917000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Liabilities Current | 967443000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Marketable Securities Current | 3131463000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Net Income Loss Attributable To Noncontrolling Interest | 3686000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Operating Income Loss | 80881000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Nonoperating Income Expense | -3173000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 77573000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Property Plant And Equipment Net | 39638000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 634338000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; | ||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 164748000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= Rest Of World; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3560965000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 85945000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5611000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5003275000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2360000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 14000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Repurchased During Period Value | 9000000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Stock Repurchased During Period Value | 9000000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 125817000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Assets | 6736917000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Accounts Receivable Net Current | 725205000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -2994000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Additional Paid In Capital | 10398181000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2119936000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -310442000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Shares Authorized | 2700000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Outstanding | 2262655000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Outstanding | 2359663000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | 3686000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | 99550000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Income Tax Expense Benefit | 5599000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 22395000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Increase Decrease In Accounts Receivable | 121884000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Increase Decrease In Accounts Receivable | 134959000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -22924000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Net Cash Provided By Used In Operating Activities | 310263000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Net Income Loss | 105530000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Operating Expenses | 437201000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Operating Lease Liability Current | 43993000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Other Assets Noncurrent | 166217000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -1899000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Payments For Repurchase Of Common Stock | 9000000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Profit Loss | 105530000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20250331 | Profit Loss | 217717000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Profit Loss | 214031000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20240331 | Research And Development Expense | 110040000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Research And Development Expense | 134889000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 298965000.0000 | USD | 1 | us-gaap/2025 | Business Segments= Commercial Operating Segment; Consolidation Items= Operating Segments; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 486963000.0000 | USD | 1 | us-gaap/2025 | Business Segments= Government Operating Segment; Consolidation Items= Operating Segments; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 883855000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 5100000.0000 | USD | 1 | us-gaap/2025 | Type Of Arrangement= Investment Agreement; Type Of Contract= Commercial Contract; | ||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3861172000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 3775227000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 10193970000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5424155000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 7505000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 13574000.0000 | shares | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 66584000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 2213545000.0000 | shares | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -5611000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 155646000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 155646000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20240331 | Cash And Cash Equivalents At Carrying Value | 520388000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Cash And Cash Equivalents At Carrying Value | 993464000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1104931000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Shares Authorized | 22701005000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Shares Outstanding | 2338795000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Comprehensive Income Net Of Tax | 216648000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Debt And Equity Securities Unrealized Gain Loss | -12354000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Depreciation Depletion And Amortization | 8438000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Earnings Per Share Diluted | 0.0400 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Gross Profit | 710885000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 110726000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Income Tax Expense Benefit | 4655000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Increase Decrease In Contract With Customer Liability | 18760000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Increase Decrease In Other Operating Liabilities | -15515000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Liabilities And Stockholders Equity | 6340884000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Marketable Securities Current | 4437225000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Net Cash Provided By Used In Investing Activities | -511245000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Expenses | 5000000.0000 | USD | 1 | us-gaap/2025 | Related Party Transactions By Related Party= Chief Executive Officer; | ||
0001321655-25-000066 | 20241231 | Operating Lease Liability Noncurrent | 195226000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 2617000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20240331 | Payments For Proceeds From Other Investing Activities | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Payments For Repurchase Of Common Stock | 17998000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Proceeds From Payments For Other Financing Activities | 90000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Proceeds From Stock Options Exercised | 83840000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5187423000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -7000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 66584000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 2552818000.0000 | shares | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Accounts Payable Current | 2330000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 125817000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 850107000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 539665000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Authorized | 20000000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Issued | 95401000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Issued | 2262655000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Issued | 96003000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class B; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Issued | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Outstanding | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Outstanding | 2359663000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Cost Of Revenue | 172970000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Customer Deposit Current | 265252000.0000 | USD | 0 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20250331 | Customer Deposit Noncurrent | 1463000.0000 | USD | 0 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20250331 | Deferred Revenue Current | 318556000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Deferred Revenue Noncurrent | 36372000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | 0.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Earnings Per Share Basic | 0.0500 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Earnings Per Share Diluted | 0.0800 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -4024000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | General And Administrative Expense | 133984000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Minority Interest | 91132000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Minority Interest | 94818000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Net Cash Provided By Used In Operating Activities | 129579000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Expenses | 534837000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Operating Income Loss | 176048000.0000 | USD | 1 | us-gaap/2025 | Consolidation Items= Material Reconciling Items; | ||
0001321655-25-000066 | 20240331 | Other Operating Activities Cash Flow Statement | 5592000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Payments To Acquire Marketable Securities | 1260327000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Payments To Acquire Marketable Securities | 1704720000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Payments To Acquire Property Plant And Equipment | 6184000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Prepaid Expense And Other Assets Current | 126705000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Profit Loss | 541000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9122173000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5720000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
0001321655-25-000066 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2339000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 5518973000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 94818000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Noncontrolling Interest; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 83840000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20240331 | Stock Repurchased During Period Value | 9000000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20241231 | Assets Current | 5934289000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20250331 | Common Stock Shares Authorized | 22701005000.0000 | shares | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Common Stock Shares Authorized | 1005000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class F; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Issued | 2242389000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20241231 | Common Stock Shares Outstanding | 2242389000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Common Class A; | ||
0001321655-25-000066 | 20250331 | Depreciation Depletion And Amortization | 6622000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3980000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Gross Profit | 518082000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 4704000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -40730000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Liabilities Current | 996018000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Noncash Consideration | -17313000.0000 | USD | 1 | 0001321655-25-000066 | |||
0001321655-25-000066 | 20250331 | Operating Lease Liability Current | 44419000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -6521000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 2617000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Other Nonoperating Income Expense | -13507000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Payments For Proceeds From Other Investing Activities | 30000000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Prepaid Expense And Other Assets Current | 129254000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Proceeds From Payments For Other Financing Activities | 408000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Profit Loss | 105530000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20250331 | Profit Loss | 214031000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Parent; | ||
0001321655-25-000066 | 20241231 | Retained Earnings Accumulated Deficit | -5187423000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 634338000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 396892000.0000 | USD | 1 | us-gaap/2025 | Business Segments= Commercial Operating Segment; Consolidation Items= Operating Segments; | ||
0001321655-25-000066 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 89654000.0000 | USD | 1 | us-gaap/2025 | Concentration Risk By Type= Geographic Concentration Risk; Geographical= G B; | ||
0001321655-25-000066 | 20250331 | Share Based Compensation | 155339000.0000 | USD | 1 | us-gaap/2025 | |||
0001321655-25-000066 | 20241231 | Stockholders Equity | 5003275000.0000 | USD | 0 | us-gaap/2025 | |||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9322803000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
0001321655-25-000066 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2227000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 17482000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
0001321655-25-000066 | 20250331 | Stock Repurchased During Period Value | 17998000.0000 | USD | 1 | us-gaap/2025 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Increase Decrease In Contract With Customer Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Stock Repurchased During Period Value | us-gaap/2025 | 0 | 0 | monetary | D | D | Stock Repurchased During Period, Value | Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. |
Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Profit Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Minority Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity. |
Other Operating Activities Cash Flow Statement | us-gaap/2025 | 0 | 0 | monetary | D | D | Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item | Amount of cash inflow (outflow) from operating activity, classified as other, in reconciling net income to reflect cash provided by (used in) operating activity when indirect cash flow method is applied. |
Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
Depreciation Depletion And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Debt And Equity Securities Unrealized Gain Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Debt and Equity Securities, Unrealized Gain (Loss) | Amount of unrealized gain (loss) on investment in debt and equity securities. |
Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Payments For Repurchase Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
Payments To Acquire Marketable Securities | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Payments For Proceeds From Other Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment for (Proceeds from) Other Investing Activity | Amount of cash (inflow) outflow from investing activity, classified as other. |
Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Accounts Receivable Net Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
Cost Of Revenue | us-gaap/2025 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Net Income (Loss) Attributable to Noncontrolling Interest | Amount of Net Income (Loss) attributable to noncontrolling interest. |
Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
Selling And Marketing Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Increase Decrease In Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Operating Liabilities | Amount of increase (decrease) in operating liabilities classified as other. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. |
Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Deferred Revenue Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. |
Marketable Securities Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
Noncash Consideration | 0001321655-25-000066 | 1 | 0 | monetary | D | D | Noncash Consideration | Noncash Consideration |
Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Increase Decrease In Accounts Receivable | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Other Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Deferred Revenue Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
Stock Repurchased During Period Shares | us-gaap/2025 | 0 | 0 | shares | D | Stock Repurchased During Period, Shares | Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | |
Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Gross Profit | us-gaap/2025 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | D | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
Proceeds From Payments For Other Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from (Payment for) Other Financing Activity | Amount of cash inflow (outflow) from financing activity, classified as other. |
Proceeds From Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
Customer Deposit Current | 0001321655-25-000066 | 1 | 0 | monetary | I | C | Customer Deposit, Current | Customer deposit current. |
Customer Deposit Noncurrent | 0001321655-25-000066 | 1 | 0 | monetary | I | C | Customer Deposit, Noncurrent | Customer deposit noncurrent. |
Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001321655-25-000066 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
0001321655-25-000066 | 2 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2025 | Marketable securities | 0 |
0001321655-25-000066 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2025 | Accounts receivable, net | 0 |
0001321655-25-000066 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
0001321655-25-000066 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
0001321655-25-000066 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
0001321655-25-000066 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use assets | 0 |
0001321655-25-000066 | 2 | 10 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other assets | 0 |
0001321655-25-000066 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
0001321655-25-000066 | 2 | 14 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
0001321655-25-000066 | 2 | 15 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued liabilities | 0 |
0001321655-25-000066 | 2 | 16 | BS | 0 | H | Deferred Revenue Current | us-gaap/2025 | Deferred revenue | 0 |
0001321655-25-000066 | 2 | 17 | BS | 0 | H | Customer Deposit Current | 0001321655-25-000066 | Customer deposits | 0 |
0001321655-25-000066 | 2 | 18 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Operating lease liabilities | 0 |
0001321655-25-000066 | 2 | 19 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
0001321655-25-000066 | 2 | 20 | BS | 0 | H | Deferred Revenue Noncurrent | us-gaap/2025 | Deferred revenue, noncurrent | 0 |
0001321655-25-000066 | 2 | 21 | BS | 0 | H | Customer Deposit Noncurrent | 0001321655-25-000066 | Customer deposits, noncurrent | 0 |
0001321655-25-000066 | 2 | 22 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease liabilities, noncurrent | 0 |
0001321655-25-000066 | 2 | 23 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other noncurrent liabilities | 0 |
0001321655-25-000066 | 2 | 24 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
0001321655-25-000066 | 2 | 25 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and Contingencies (Note 7) | 0 |
0001321655-25-000066 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock | 0 |
0001321655-25-000066 | 2 | 28 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
0001321655-25-000066 | 2 | 29 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive income (loss), net | 0 |
0001321655-25-000066 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
0001321655-25-000066 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total Palantir's stockholders equity | 0 |
0001321655-25-000066 | 2 | 32 | BS | 0 | H | Minority Interest | us-gaap/2025 | Noncontrolling interests | 0 |
0001321655-25-000066 | 2 | 33 | BS | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Total equity | 0 |
0001321655-25-000066 | 2 | 34 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and equity | 0 |
0001321655-25-000066 | 3 | 8 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in dollars per share) | 0 |
0001321655-25-000066 | 3 | 9 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized (in shares) | 0 |
0001321655-25-000066 | 3 | 10 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued (in shares) | 0 |
0001321655-25-000066 | 3 | 11 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding (in shares) | 0 |
0001321655-25-000066 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2025 | Revenue | 0 |
0001321655-25-000066 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2025 | Cost of revenue | 0 |
0001321655-25-000066 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2025 | Gross profit | 0 |
0001321655-25-000066 | 4 | 5 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2025 | Sales and marketing | 0 |
0001321655-25-000066 | 4 | 6 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
0001321655-25-000066 | 4 | 7 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
0001321655-25-000066 | 4 | 8 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
0001321655-25-000066 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Income from operations | 0 |
0001321655-25-000066 | 4 | 10 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest income | 0 |
0001321655-25-000066 | 4 | 11 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2025 | Other income (expense), net | 0 |
0001321655-25-000066 | 4 | 12 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Income before provision for income taxes | 0 |
0001321655-25-000066 | 4 | 13 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Provision for income taxes | 0 |
0001321655-25-000066 | 4 | 14 | IS | 0 | H | Profit Loss | us-gaap/2025 | Net income | 0 |
0001321655-25-000066 | 4 | 15 | IS | 0 | H | Net Income Loss Attributable To Noncontrolling Interest | us-gaap/2025 | Less: Net income attributable to noncontrolling interests | 0 |
0001321655-25-000066 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net income attributable to common stockholders | 0 |
0001321655-25-000066 | 4 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net earnings per share attributable to common stockholders, basic (in dollars per share) | 0 |
0001321655-25-000066 | 4 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Net earnings per share attributable to common stockholders, diluted (in dollars per share) | 0 |
0001321655-25-000066 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, basic (in shares) | 0 |
0001321655-25-000066 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted-average shares of common stock outstanding used in computing net earnings per share attributable to common stockholders, diluted (in shares) | 0 |
0001321655-25-000066 | 5 | 1 | CI | 0 | H | Profit Loss | us-gaap/2025 | Net income | 0 |
0001321655-25-000066 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2025 | Foreign currency translation adjustments | 0 |
0001321655-25-000066 | 5 | 4 | CI | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2025 | Net unrealized loss on available-for-sale securities | 0 |
0001321655-25-000066 | 5 | 5 | CI | 0 | H | Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Comprehensive income | 0 |
0001321655-25-000066 | 5 | 6 | CI | 0 | H | Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | us-gaap/2025 | Less: Comprehensive income attributable to noncontrolling interests | 0 |
0001321655-25-000066 | 5 | 7 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive income attributable to common stockholders | 0 |
0001321655-25-000066 | 6 | 12 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2025 | Beginning balance (in shares) | 0 |
0001321655-25-000066 | 6 | 13 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Beginning balance | 0 |
0001321655-25-000066 | 6 | 14 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | Issuance of common stock from the exercise of stock options (in shares) | 0 |
0001321655-25-000066 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | Issuance of common stock from the exercise of stock options | 0 |
0001321655-25-000066 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) | 0 |
0001321655-25-000066 | 6 | 17 | EQ | 0 | H | Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | us-gaap/2025 | Issuance of common stock upon vesting of restricted stock units (RSUs) | 0 |
0001321655-25-000066 | 6 | 18 | EQ | 0 | H | Stock Repurchased During Period Shares | us-gaap/2025 | Repurchases of common stock (in shares) | 1 |
0001321655-25-000066 | 6 | 19 | EQ | 0 | H | Stock Repurchased During Period Value | us-gaap/2025 | Repurchases of common stock | 1 |
0001321655-25-000066 | 6 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
0001321655-25-000066 | 6 | 21 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Other comprehensive income (loss) | 0 |
0001321655-25-000066 | 6 | 22 | EQ | 0 | H | Profit Loss | us-gaap/2025 | Net income | 0 |
0001321655-25-000066 | 6 | 23 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2025 | Ending balance (in shares) | 0 |
0001321655-25-000066 | 6 | 24 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2025 | Ending balance | 0 |
0001321655-25-000066 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2025 | Net income | 0 |
0001321655-25-000066 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
0001321655-25-000066 | 7 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation | 0 |
0001321655-25-000066 | 7 | 6 | CF | 0 | H | Debt And Equity Securities Unrealized Gain Loss | us-gaap/2025 | Unrealized and realized (gain) loss from marketable securities, net | 1 |
0001321655-25-000066 | 7 | 7 | CF | 0 | H | Noncash Consideration | 0001321655-25-000066 | Noncash consideration | 0 |
0001321655-25-000066 | 7 | 8 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2025 | Other operating activities | 0 |
0001321655-25-000066 | 7 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2025 | Accounts receivable, net | 1 |
0001321655-25-000066 | 7 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other assets | 1 |
0001321655-25-000066 | 7 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2025 | Accounts payable and accrued liabilities | 0 |
0001321655-25-000066 | 7 | 13 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2025 | Contract liabilities | 0 |
0001321655-25-000066 | 7 | 14 | CF | 0 | H | Increase Decrease In Other Operating Liabilities | us-gaap/2025 | Other liabilities | 0 |
0001321655-25-000066 | 7 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash provided by operating activities | 0 |
0001321655-25-000066 | 7 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
0001321655-25-000066 | 7 | 18 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2025 | Purchases of marketable securities | 1 |
0001321655-25-000066 | 7 | 19 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2025 | Proceeds from sales and redemption of marketable securities | 0 |
0001321655-25-000066 | 7 | 20 | CF | 0 | H | Payments For Proceeds From Other Investing Activities | us-gaap/2025 | Other investing activities | 1 |
0001321655-25-000066 | 7 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash used in investing activities | 0 |
0001321655-25-000066 | 7 | 23 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2025 | Proceeds from the exercise of common stock options | 0 |
0001321655-25-000066 | 7 | 24 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2025 | Repurchases of common stock | 1 |
0001321655-25-000066 | 7 | 25 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | Taxes paid related to net share settlement of equity awards | 1 |
0001321655-25-000066 | 7 | 26 | CF | 0 | H | Proceeds From Payments For Other Financing Activities | us-gaap/2025 | Other financing activities | 0 |
0001321655-25-000066 | 7 | 27 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by (used in) financing activities | 0 |
0001321655-25-000066 | 7 | 28 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Effect of foreign exchange on cash, cash equivalents, and restricted cash | 0 |
0001321655-25-000066 | 7 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net decrease in cash, cash equivalents, and restricted cash | 0 |
0001321655-25-000066 | 7 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents, and restricted cash - beginning of period | 0 |
0001321655-25-000066 | 7 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents, and restricted cash - end of period | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |